The 20 Largest Medical Device Companies In the World

When it comes to the largest medical device companies, it’s a changing cast of players – as demonstrated once again in Medical Design & Outsourcing’s latest Big 100 list. We pulled financial regulatory filings and reached out to major companies in some cases to create a list of the 100 largest medical device companies in

Pages: 1 2 3 4 5 6 7 8 9 10 11

Webinar: How late 2017 has changed medtech

This webinar was presented live on Wednesday, October 11, 2017. Click below to watch on demand.       When it comes to news out of the U.S. government: one word could sum up what it means for the medical device industry: “uncertainty.” It was true at the start of 2017. And it is even

Medtronic, Mazor Robotics close $40 million round

Mazor Robotics (NSDQ:MZOR) said today that closed the third, $40 million tranche of a deal with Medtronic (NYSE:MDT), which is due to take on exclusive global distribution rights for the Mazor X robot-assisted surgery device. It’s the third investment in the Israeli surgical robotics concern for Fridley, Minn.-based Medtronic, taking its total investment to $72 million, 10.6% stake in…

The 10 largest medtech employers – and what their workers really think

Among the 10 largest medtech employers, workers feel pride in working on life-saving products – but there’s also frustration with big corporate bureaucracy. That was the major takeaway as Medical Design & Outsourcing compiled some of the most insightful current and former employee reviews posted on Glassdoor. The 10 companies we’re counting down were the

Pages: 1 2 3 4 5 6 7 8 9 10 11

Abiomed buys Danvers, Mass. HQ for $17m

Abiomed (NSDQ:ABMD) said this week it inked a deal to purchase its existing corporate headquarters in Danvers, Mass. for $16.5 million. The company said that it opted to buy the facilities, which includes 12 acres of land and all associated buildings, structures and other improvements, through an option in its existing lease with the original owners. Abiomed […]

TransMed7 and Peridot forge medical device development partnership

TransMed7 announced that it has entered a strategic partnership with Peridot Corp. went into effect on Aug. 21. The two privately-held companies design and develop medical device technologies and offer end-to-end precision manufacturing and clean room assembly services. “This new strategic partnership with Peridot enables TransMed7 to launch new products such as our Concorde and

RightEye raises $7.3 million from VSP Global, angel investors

Eyecare company VSP Global said today that it has made an investment in RightEye and its game-based vision tests. VSP (Rancho Cordova, Calif.) did not disclose the amount it provided RightEye (Bethesda, Md.) in the Series A round. But an SEC Form D that RightEye filed in June shows a roughly $7.3 million money-raise, which a spokesperson for

3D-printed organ developer BioLife4D seeks $50 million IPO

Biological 3D printing developer BioLife4D has filed for a $50 million initial public offering as it looks to commercialize its cardiac tissue regeneration and organ replacement processes. The Chicago-based company said yesterday it is developing technologies with an end goal of creating a 3D bioprinted viable human heart suitable for transplant. Funds from the offering

Micronet Enertec wins $650,000 medtech testing systems contract

Micronet Enertec Technologies (Nasdaq: MICT) said today that its wholly-owned Enertec Systems 2001 subsidiary, Enertec Systems 2001 has secured a $650,000 purchase order from an undisclosed Fortune 50 multi-national medical device company. The purchase order involves Enertec creating fully automated testing systems for medical calibration devices treating heart rhythm disorders. It’s the largest order Entertec

Founder & CEO buy adds $570k to Retractable Technologies stake

Retractable Technologies‘ (NYSE:RVP) founder & CEO, Thomas Shaw, bought 1 million shares of common stock in the company at 57¢ apiece, according to a regulatory filing. The move comes just days after a federal appeals court ruled that Becton Dickinson & Co. (NYSE:BDX) owes nothing in a case brought by the Little Elm, Texas-based company. Get the full story

Wearable sensor developer MC10 raises $9.2m

MC10, a Lexington, Mass.–based wearable sensor developer, raised $9.2 million in an offering of promissory notes and warrants convertible into preferred stock to 18 investors, according to regulatory filing. The flexible electronics company still needs to raise $767,038 to reach the offering’s $10 million total. MC10’s BioStamp wearable sensors collect and transmit biometric data, allowing

Titan Medical closes $2m deal with Chinese investor

Titan Medical (TSX:TMD) said today that it closed a deal with Longtai Medical to convert a $2 million distributorship deposit to equity. The move makes Longtai the robotic surgical company’s largest shareholder. In May of 2015, Titan Medical and Longtai, a subsidiary of Chinese medical device distributor Ningbo Long Hengtai International Trade Co., inked a deal to

Sirtex swings to a loss after ‘challenging’ year

Shares in Australian cancer treatment developer Sirtex Medical (ASX:SRX) plunged more than 15% yesterday after the company posted a net loss of -A$26.9 million in 2016, compared to a profit of A$54 million the year before. Sirtex has faced a barrage of obstacles this year, including a number of clinical trials that failed to meet primary endpoints.

Fujifilm announces U.S. customer wins for Synapse imaging system

Fujifilm Medical Systems U.S.A. said today that seven U.S. healthcare systems are picking up various products from the company’s Synapse enterprise imaging portfolio. The health systems includeHackensack Meridian Health and West Virginia University Health System – two of the largest healthcare networks in the mid-Atlantic region. Products bought include the Synapse 5 PACS, Synapse VNA, Synapse

Medpace announces $60M stock repurchase agreement

Medpace Holdings (Nasdaq: MEDP) is spending about $60.5 million to repurchase stock. The stock repurchase agreement with Cinven Capital Management (V) General Partner Limited, announced yesterday, involves Medpace repurchasing 2 million shares of stock at a price of $30.27 per share. The transaction is expected to close tomorrow, subject to customary closing conditions. The company’s stock